Do you want to read an article? Please log in or register.
Pneumocystis jiroveci pneumonia in rheumatic disease: a 20-year single-centre experience.
Interstitial Lung DiseasePneumonia
Related content
Determining the Incidence of Pneumocystis Pneumonia in Patients With Autoimmune Blistering Diseases Not Receiving Routine Prophylaxis
JAMA Dermatol.
Amber KT, Lamberts A, Solimani F, Agnoletti AF, Didona D, Euverman I, Cozzani E, Yueh LH, Di Zenzo G, Leshem YA, Mimouni D, Hertl M, Horvath B
doi: 10.1001/
RECOMMENDED
ARDSPneumonia
Clinical course, treatment and outcome of Pneumocystis pneumonia in immunocompromised adults: a retrospective analysis over 17 years
Crit Care.
Schmidt JJ, Lueck C, Ziesing S, Stoll M, Haller H, Gottlieb J, Eder M, Welte T, Hoeper MM, Scherag A, David S
doi: 10.1186/s13054-018-2221-8.
COPD
Global, regional, and national deaths, prevalence, disability-adjusted life years, and years lived with disability for chronic obstructive pulmonary disease and asthma, 1990-2015: a systematic analysis for the Global Burden of Disease Study 2015
Lancet Respir Med.
GBD 2015 Chronic Respiratory Disease Collaborators
doi: 10.1016/S2213-2600
RECOMMENDED
Further Publications
One-year outcome of critically ill patients with systemic rheumatic disease: a multicenter cohort study
★ 2
Recommended by
Dr Martin Frey, Faculty Member
★ 2
Recommended by
Dr Marcus Hesse, Faculty Member
doi: 10.1016/j.chest.2020.03.050.
RECOMMENDED
Interstitial Lung Disease
The Spectrum of Interstitial Lung Disease Associated with Autoimmune Diseases: Data of a 3.6-Year Prospective Study from a Referral Center of Interstitial Lung Disease and Lung Transplantation
★ 2
Recommended by
Dr Martin Frey, Faculty Member
J Clin Med.
Atienza-Mateo B, Remuzgo-Martínez S, Mora Cuesta VM, Iturbe-Fernández D, Fernández-Rozas S, Prieto-Peña D, Calderón-Goercke M, Corrales A, Blanco Rodríguez GB, Gómez-Román JJ, González-Gay MÁ, Cifrián JM
doi: 10.3390/jcm9061606.
RECOMMENDED
Pneumonia
Risk factors and prophylaxis of Pneumocystis jirovecii pneumonia in HIV-negative patients
RECOMMENDED
Lung Cancer
Significantly favourable outcome for patients with non-small-cell lung cancer stage IIIA/IIIB and single-station persistent N2 (skip or additionally N1) disease after multimodality treatment
★ 2
Recommended by
Dr Martin Frey, Faculty Member
★ 1
Recommended by
Dr Marcus Hesse, Faculty Member
Eur J Cardiothorac Surg
Stamatis G, Müller S, Weinreich G, Schwarz B, Eberhardt W, Pöttgen C, Aigner C
doi: 10.1093/ejcts/ezab372
RECOMMENDED
Pneumonia
Dihydrotestosterone is a predictor for mortality in males with community-acquired pneumonia: results of a 6-year follow-up study
Respir Res.
Zurfluh S, Nickler M, Ottiger M, Steuer C, Kutz A, Christ-Crain M, Zimmerli W, Thomann R, Hoess C, Henzen C, Bernasconi L, Huber A, Mueller B, Schuetz P; proHOSP study group
doi: 10.1186/s12931-018-0947-0.
RECOMMENDED
COPD
Triple therapy versus single and dual long-acting bronchodilator therapy in chronic obstructive pulmonary disease: a systematic review and meta-analysis
Eur Respir J.
Cazzola M, Rogliani P, Calzetta L, Matera MG
doi: 10.1183/13993003.